SCCM Resource Library-September Journal Club: Critical Care Medicine (2022)

Video Transcription

Video Summary

In this Journal Club Critical Care Medicine webcast, two articles are discussed. The first article focuses on the use of daily written care summaries for families of critically ill patients and their impact on family satisfaction. The study found that providing families with written summaries improved their understanding of the patient's condition, treatment plan, and progress. It also facilitated communication with the medical team, reduced anxiety and stress, and provided consistent communication each day. The second article discusses a clinical trial on the use of the IL-6 inhibitor, clazakizumab, in treating severe and critical COVID-19 patients with hyperinflammation. The study found that clazakizumab was associated with improved ventilator-free survival and overall survival at 28 and 60 days. Patients who received clazakizumab also had lower odds of new intubation and ICU admission, as well as improved clinical status scores. The study did not find any differences in adverse events between the clazakizumab and placebo groups. The results suggest that clazakizumab could be beneficial in less severe COVID-19 cases, and it is important to administer the drug early in the disease course. The webcast provides valuable insights into improving communication with ICU families and the potential use of IL-6 inhibitors in treating severe COVID-19 patients.

Asset Subtitle

Patient and Family Support, Infection, 2022

Asset Caption

"The Journal Club: Critical Care Medicine webcast series focuses on articles of interest from Critical Care Medicine.

This series is held on the fourth Thursday of each month and features in-depth presentations and lively discussion by the authors.

Follow the conversation at #CritCareMed."

Meta Tag

Content Type Webcast

Knowledge Area Patient and Family Support

Knowledge Area Infection

Knowledge Level Intermediate

Knowledge Level Advanced

Membership Level Professional

Membership Level Select

Tag Communication

Tag COVID-19

Year 2022

Keywords

daily written care summaries

family satisfaction

patient's condition

communication

IL-6 inhibitor

clazakizumab

severe COVID-19 patients

ventilator-free survival

clinical status scores

early administration

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.